Detection of KRAS Mutations and Their Associations with Clinicopathological Features and Survival in Chinese Colorectal Cancer Patients

By Li Z   Chen Y   Wang D   Wang G   He L   Suo J  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1589-1598

Field House Publishing

Access to resources Recommend Favorite

Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS

By Shitara Kohei   Yokota Tomoya   Takahari Daisuke   Shibata Takashi   Ura Takashi   Utsunomiya Setsuo   Inaba Yoshitaka   Yamaura Hidekazu   Sato Yozo   Najima Mina   Kawai Hiroki   Tajika Masahiro   Sawaki Akira   Yatabe Yasushi   Muro Kei  

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 688-693

Springer Publishing Company

Access to resources Recommend Favorite

Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations

By Park In   Kim Jin   Jung Jae   Han Ji-Youn  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 791-799

Springer Publishing Company

Access to resources Recommend Favorite

Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations

By  

Current Cancer Drug Targets, Vol. 18, Iss. 3, 2018-02 ,pp. : 278-286

Bentham Science Publishers

Access to resources Recommend Favorite

Setting future standards for KRAS testing in colorectal cancer

By van Krieken Han   Tol Jolien  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 1-3

Future Medicine

Access to resources Recommend Favorite